The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global IVD Antibody Market Research Report 2025
Synopsis
IVD Antibody
The global IVD Antibody market was valued at US$ 844 million in 2023 and is anticipated to reach US$ 1379 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IVD Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Antibody.
Report Scope
The IVD Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD PharMingen
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Santa Cruz Biotechnologies
Beckman Coulter
Roche/Ventana
Segment by Type
mAb
pAb
rAbs
Segment by Application
RIA
ELISA
CLIA
LFIA
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of IVD Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of IVD Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
IVD Antibody
The global IVD Antibody market was valued at US$ 844 million in 2023 and is anticipated to reach US$ 1379 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IVD Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Antibody.
Report Scope
The IVD Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD PharMingen
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Santa Cruz Biotechnologies
Beckman Coulter
Roche/Ventana
Segment by Type
mAb
pAb
rAbs
Segment by Application
RIA
ELISA
CLIA
LFIA
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of IVD Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of IVD Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 IVD Antibody Market Overview
1.1 Product Overview and Scope of IVD Antibody
1.2 IVD Antibody Segment by Type
1.2.1 Global IVD Antibody Market Value Comparison by Type (2024-2030)
1.2.2 mAb
1.2.3 pAb
1.2.4 rAbs
1.3 IVD Antibody Segment by Application
1.3.1 Global IVD Antibody Market Value by Application: (2024-2030)
1.3.2 RIA
1.3.3 ELISA
1.3.4 CLIA
1.3.5 LFIA
1.3.6 Other
1.4 Global IVD Antibody Market Size Estimates and Forecasts
1.4.1 Global IVD Antibody Revenue 2019-2030
1.4.2 Global IVD Antibody Sales 2019-2030
1.4.3 Global IVD Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IVD Antibody Market Competition by Manufacturers
2.1 Global IVD Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global IVD Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IVD Antibody Average Price by Manufacturers (2019-2024)
2.4 Global IVD Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IVD Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IVD Antibody, Product Type & Application
2.7 IVD Antibody Market Competitive Situation and Trends
2.7.1 IVD Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IVD Antibody Players Market Share by Revenue
2.7.3 Global IVD Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IVD Antibody Retrospective Market Scenario by Region
3.1 Global IVD Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IVD Antibody Global IVD Antibody Sales by Region: 2019-2030
3.2.1 Global IVD Antibody Sales by Region: 2019-2024
3.2.2 Global IVD Antibody Sales by Region: 2025-2030
3.3 Global IVD Antibody Global IVD Antibody Revenue by Region: 2019-2030
3.3.1 Global IVD Antibody Revenue by Region: 2019-2024
3.3.2 Global IVD Antibody Revenue by Region: 2025-2030
3.4 North America IVD Antibody Market Facts & Figures by Country
3.4.1 North America IVD Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IVD Antibody Sales by Country (2019-2030)
3.4.3 North America IVD Antibody Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe IVD Antibody Market Facts & Figures by Country
3.5.1 Europe IVD Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IVD Antibody Sales by Country (2019-2030)
3.5.3 Europe IVD Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IVD Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific IVD Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IVD Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific IVD Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IVD Antibody Market Facts & Figures by Country
3.7.1 Latin America IVD Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IVD Antibody Sales by Country (2019-2030)
3.7.3 Latin America IVD Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IVD Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa IVD Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IVD Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa IVD Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IVD Antibody Sales by Type (2019-2030)
4.1.1 Global IVD Antibody Sales by Type (2019-2024)
4.1.2 Global IVD Antibody Sales by Type (2025-2030)
4.1.3 Global IVD Antibody Sales Market Share by Type (2019-2030)
4.2 Global IVD Antibody Revenue by Type (2019-2030)
4.2.1 Global IVD Antibody Revenue by Type (2019-2024)
4.2.2 Global IVD Antibody Revenue by Type (2025-2030)
4.2.3 Global IVD Antibody Revenue Market Share by Type (2019-2030)
4.3 Global IVD Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global IVD Antibody Sales by Application (2019-2030)
5.1.1 Global IVD Antibody Sales by Application (2019-2024)
5.1.2 Global IVD Antibody Sales by Application (2025-2030)
5.1.3 Global IVD Antibody Sales Market Share by Application (2019-2030)
5.2 Global IVD Antibody Revenue by Application (2019-2030)
5.2.1 Global IVD Antibody Revenue by Application (2019-2024)
5.2.2 Global IVD Antibody Revenue by Application (2025-2030)
5.2.3 Global IVD Antibody Revenue Market Share by Application (2019-2030)
5.3 Global IVD Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BD PharMingen
6.1.1 BD PharMingen Corporation Information
6.1.2 BD PharMingen Description and Business Overview
6.1.3 BD PharMingen IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BD PharMingen IVD Antibody Product Portfolio
6.1.5 BD PharMingen Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Corporation Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abcam IVD Antibody Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 R&D Systems
6.3.1 R&D Systems Corporation Information
6.3.2 R&D Systems Description and Business Overview
6.3.3 R&D Systems IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 R&D Systems IVD Antibody Product Portfolio
6.3.5 R&D Systems Recent Developments/Updates
6.4 Cell Signaling Technology
6.4.1 Cell Signaling Technology Corporation Information
6.4.2 Cell Signaling Technology Description and Business Overview
6.4.3 Cell Signaling Technology IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cell Signaling Technology IVD Antibody Product Portfolio
6.4.5 Cell Signaling Technology Recent Developments/Updates
6.5 Affymatrix
6.5.1 Affymatrix Corporation Information
6.5.2 Affymatrix Description and Business Overview
6.5.3 Affymatrix IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Affymatrix IVD Antibody Product Portfolio
6.5.5 Affymatrix Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Corporation Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BioLegend IVD Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 Santa Cruz Biotechnologies
6.6.1 Santa Cruz Biotechnologies Corporation Information
6.6.2 Santa Cruz Biotechnologies Description and Business Overview
6.6.3 Santa Cruz Biotechnologies IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Santa Cruz Biotechnologies IVD Antibody Product Portfolio
6.7.5 Santa Cruz Biotechnologies Recent Developments/Updates
6.8 Beckman Coulter
6.8.1 Beckman Coulter Corporation Information
6.8.2 Beckman Coulter Description and Business Overview
6.8.3 Beckman Coulter IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Beckman Coulter IVD Antibody Product Portfolio
6.8.5 Beckman Coulter Recent Developments/Updates
6.9 Roche/Ventana
6.9.1 Roche/Ventana Corporation Information
6.9.2 Roche/Ventana Description and Business Overview
6.9.3 Roche/Ventana IVD Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche/Ventana IVD Antibody Product Portfolio
6.9.5 Roche/Ventana Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IVD Antibody Industry Chain Analysis
7.2 IVD Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IVD Antibody Production Mode & Process
7.4 IVD Antibody Sales and Marketing
7.4.1 IVD Antibody Sales Channels
7.4.2 IVD Antibody Distributors
7.5 IVD Antibody Customers
8 IVD Antibody Market Dynamics
8.1 IVD Antibody Industry Trends
8.2 IVD Antibody Market Drivers
8.3 IVD Antibody Market Challenges
8.4 IVD Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global IVD Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global IVD Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global IVD Antibody Market Competitive Situation by Manufacturers in 2023
Table 4. Global IVD Antibody Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global IVD Antibody Sales Market Share by Manufacturers (2019-2024)
Table 6. Global IVD Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global IVD Antibody Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market IVD Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of IVD Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of IVD Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of IVD Antibody, Product Type & Application
Table 12. Global Key Manufacturers of IVD Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IVD Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibody as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IVD Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global IVD Antibody Sales by Region (2019-2024) & (K Units)
Table 18. Global IVD Antibody Sales Market Share by Region (2019-2024)
Table 19. Global IVD Antibody Sales by Region (2025-2030) & (K Units)
Table 20. Global IVD Antibody Sales Market Share by Region (2025-2030)
Table 21. Global IVD Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global IVD Antibody Revenue Market Share by Region (2019-2024)
Table 23. Global IVD Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global IVD Antibody Revenue Market Share by Region (2025-2030)
Table 25. North America IVD Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America IVD Antibody Sales by Country (2019-2024) & (K Units)
Table 27. North America IVD Antibody Sales by Country (2025-2030) & (K Units)
Table 28. North America IVD Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America IVD Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe IVD Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe IVD Antibody Sales by Country (2019-2024) & (K Units)
Table 32. Europe IVD Antibody Sales by Country (2025-2030) & (K Units)
Table 33. Europe IVD Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe IVD Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific IVD Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific IVD Antibody Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific IVD Antibody Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific IVD Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific IVD Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America IVD Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America IVD Antibody Sales by Country (2019-2024) & (K Units)
Table 42. Latin America IVD Antibody Sales by Country (2025-2030) & (K Units)
Table 43. Latin America IVD Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America IVD Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa IVD Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa IVD Antibody Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa IVD Antibody Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa IVD Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa IVD Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global IVD Antibody Sales (K Units) by Type (2019-2024)
Table 51. Global IVD Antibody Sales (K Units) by Type (2025-2030)
Table 52. Global IVD Antibody Sales Market Share by Type (2019-2024)
Table 53. Global IVD Antibody Sales Market Share by Type (2025-2030)
Table 54. Global IVD Antibody Revenue (US$ Million) by Type (2019-2024)
Table 55. Global IVD Antibody Revenue (US$ Million) by Type (2025-2030)
Table 56. Global IVD Antibody Revenue Market Share by Type (2019-2024)
Table 57. Global IVD Antibody Revenue Market Share by Type (2025-2030)
Table 58. Global IVD Antibody Price (US$/Unit) by Type (2019-2024)
Table 59. Global IVD Antibody Price (US$/Unit) by Type (2025-2030)
Table 60. Global IVD Antibody Sales (K Units) by Application (2019-2024)
Table 61. Global IVD Antibody Sales (K Units) by Application (2025-2030)
Table 62. Global IVD Antibody Sales Market Share by Application (2019-2024)
Table 63. Global IVD Antibody Sales Market Share by Application (2025-2030)
Table 64. Global IVD Antibody Revenue (US$ Million) by Application (2019-2024)
Table 65. Global IVD Antibody Revenue (US$ Million) by Application (2025-2030)
Table 66. Global IVD Antibody Revenue Market Share by Application (2019-2024)
Table 67. Global IVD Antibody Revenue Market Share by Application (2025-2030)
Table 68. Global IVD Antibody Price (US$/Unit) by Application (2019-2024)
Table 69. Global IVD Antibody Price (US$/Unit) by Application (2025-2030)
Table 70. BD PharMingen Corporation Information
Table 71. BD PharMingen Description and Business Overview
Table 72. BD PharMingen IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. BD PharMingen IVD Antibody Product
Table 74. BD PharMingen Recent Developments/Updates
Table 75. Abcam Corporation Information
Table 76. Abcam Description and Business Overview
Table 77. Abcam IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Abcam IVD Antibody Product
Table 79. Abcam Recent Developments/Updates
Table 80. R&D Systems Corporation Information
Table 81. R&D Systems Description and Business Overview
Table 82. R&D Systems IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. R&D Systems IVD Antibody Product
Table 84. R&D Systems Recent Developments/Updates
Table 85. Cell Signaling Technology Corporation Information
Table 86. Cell Signaling Technology Description and Business Overview
Table 87. Cell Signaling Technology IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Cell Signaling Technology IVD Antibody Product
Table 89. Cell Signaling Technology Recent Developments/Updates
Table 90. Affymatrix Corporation Information
Table 91. Affymatrix Description and Business Overview
Table 92. Affymatrix IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Affymatrix IVD Antibody Product
Table 94. Affymatrix Recent Developments/Updates
Table 95. BioLegend Corporation Information
Table 96. BioLegend Description and Business Overview
Table 97. BioLegend IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. BioLegend IVD Antibody Product
Table 99. BioLegend Recent Developments/Updates
Table 100. Santa Cruz Biotechnologies Corporation Information
Table 101. Santa Cruz Biotechnologies Description and Business Overview
Table 102. Santa Cruz Biotechnologies IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Santa Cruz Biotechnologies IVD Antibody Product
Table 104. Santa Cruz Biotechnologies Recent Developments/Updates
Table 105. Beckman Coulter Corporation Information
Table 106. Beckman Coulter Description and Business Overview
Table 107. Beckman Coulter IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Beckman Coulter IVD Antibody Product
Table 109. Beckman Coulter Recent Developments/Updates
Table 110. Roche/Ventana Corporation Information
Table 111. Roche/Ventana Description and Business Overview
Table 112. Roche/Ventana IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Roche/Ventana IVD Antibody Product
Table 114. Roche/Ventana Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. IVD Antibody Distributors List
Table 118. IVD Antibody Customers List
Table 119. IVD Antibody Market Trends
Table 120. IVD Antibody Market Drivers
Table 121. IVD Antibody Market Challenges
Table 122. IVD Antibody Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of IVD Antibody
Figure 2. Global IVD Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global IVD Antibody Market Share by Type in 2023 & 2030
Figure 4. mAb Product Picture
Figure 5. pAb Product Picture
Figure 6. rAbs Product Picture
Figure 7. Global IVD Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global IVD Antibody Market Share by Application in 2023 & 2030
Figure 9. RIA
Figure 10. ELISA
Figure 11. CLIA
Figure 12. LFIA
Figure 13. Other
Figure 14. Global IVD Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global IVD Antibody Market Size (2019-2030) & (US$ Million)
Figure 16. Global IVD Antibody Sales (2019-2030) & (K Units)
Figure 17. Global IVD Antibody Average Price (US$/Unit) & (2019-2030)
Figure 18. IVD Antibody Report Years Considered
Figure 19. IVD Antibody Sales Share by Manufacturers in 2023
Figure 20. Global IVD Antibody Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest IVD Antibody Players: Market Share by Revenue in 2023
Figure 22. IVD Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global IVD Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America IVD Antibody Sales Market Share by Country (2019-2030)
Figure 25. North America IVD Antibody Revenue Market Share by Country (2019-2030)
Figure 26. United States IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe IVD Antibody Sales Market Share by Country (2019-2030)
Figure 29. Europe IVD Antibody Revenue Market Share by Country (2019-2030)
Figure 30. Germany IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific IVD Antibody Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific IVD Antibody Revenue Market Share by Region (2019-2030)
Figure 37. China IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America IVD Antibody Sales Market Share by Country (2019-2030)
Figure 47. Latin America IVD Antibody Revenue Market Share by Country (2019-2030)
Figure 48. Mexico IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa IVD Antibody Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa IVD Antibody Revenue Market Share by Country (2019-2030)
Figure 53. Turkey IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE IVD Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of IVD Antibody by Type (2019-2030)
Figure 57. Global Revenue Market Share of IVD Antibody by Type (2019-2030)
Figure 58. Global IVD Antibody Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of IVD Antibody by Application (2019-2030)
Figure 60. Global Revenue Market Share of IVD Antibody by Application (2019-2030)
Figure 61. Global IVD Antibody Price (US$/Unit) by Application (2019-2030)
Figure 62. IVD Antibody Value Chain
Figure 63. IVD Antibody Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
